CCDC85C and KCNB2 have both previously been found to be altered in screening for biomarkers with significantly higher levels in RA patients compared with healthy controls and osteoarthritis (OA) patients, respectively [12]. The gene discussed is KCNB2; the disease is osteoarthritis.